Haiwei He

Part of Asia Leechdom Holding Corp., Tianjin BOAI Pharmaceutical Co. Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Tianjin, China. Tianjin BOAI Pharmaceutical Co. was acquired by Asia Leechdom Holding Corp. on June 24, 2008 for $1.13 million. The Chinese company was founded by Haiwei He.

Asia Leechdom Holding Corp. manufactures and distributes pharmaceutical products. They are a producer and distributor of pharmaceutical products including a variety of medical supplies, prescription and over-the-counter, or OTC, drugs in China and abroad. Through their wholly-owned PRC subsidiary, BOAI Pharm and BOAI Pharm's wholly-owned subsidiary, BOAI Leechdom, they produce and sell medicines and distribute medicines and medical devices for third-party producers and manufacturers. They market their products through a sales network covering provinces and municipalities in China, including Beijing, Shanghai, Shandong, and Guangdong. They also export their products through third-party exporters to customers in North America, Europe and East Asia. Their subsidiary, BOAI Pharm is the original design manufacturer, or ODM, for twelve products branded by both domestic and international pharmaceutical companies. Their ODM Products, including products sold under the 'American Ginseng Tea,' 'Wild Ginseng Tea,' and 'Ginseng Tea,' brands are exported to end-users in Canada, Europe and Asia through the Northern International Group Tianjin Pharmaceutical Import and Export Co., Ltd., or Northern International. They receive product orders from Northern International along with a deposit for such products. They then arrange for the production, packaging and transportation of the product to a warehouse designated by Northern International and then receive payment. They produce their products at production facility located in Tianjin, China. They operate production lines, each serving the following product formats: (1) ointment, (2) pill, (3) tablet, (4) syrup, (5) granule, (6) capsule, (7) orally taken liquid, (8) plaster and (9) extract; and further separated into liquid preparations (such as ointment and syrup) and solid preparations (such as tablets, pills and granules). They recently obtained land use rights for another 85,938.92 square meters of property for construction of an additional production facility in Tianjin.

Asia Leechdom Holding Corp. manufactures and distributes pharmaceutical products. They are a producer and distributor of pharmaceutical products including a variety of medical supplies, prescription and over-the-counter, or OTC, drugs in China and abroad. Through their wholly-owned PRC subsidiary, BOAI Pharm and BOAI Pharm's wholly-owned subsidiary, BOAI Leechdom, they produce and sell medicines and distribute medicines and medical devices for third-party producers and manufacturers. They market their products through a sales network covering provinces and municipalities in China, including Beijing, Shanghai, Shandong, and Guangdong. They also export their products through third-party exporters to customers in North America, Europe and East Asia. Their subsidiary, BOAI Pharm is the original design manufacturer, or ODM, for twelve products branded by both domestic and international pharmaceutical companies. Their ODM Products, including products sold under the 'American Ginseng Tea,' 'Wild Ginseng Tea,' and 'Ginseng Tea,' brands are exported to end-users in Canada, Europe and Asia through the Northern International Group Tianjin Pharmaceutical Import and Export Co., Ltd., or Northern International. They receive product orders from Northern International along with a deposit for such products. They then arrange for the production, packaging and transportation of the product to a warehouse designated by Northern International and then receive payment. They produce their products at production facility located in Tianjin, China. They operate production lines, each serving the following product formats: (1) ointment, (2) pill, (3) tablet, (4) syrup, (5) granule, (6) capsule, (7) orally taken liquid, (8) plaster and (9) extract; and further separated into liquid preparations (such as ointment and syrup) and solid preparations (such as tablets, pills and granules). They recently obtained land use rights for another 85,938.92 square meters of property for construction of an additional production facility in Tianjin.

Part of Asia Leechdom Holding Corp., Tianjin BOAI Pharmaceutical Co. Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Tianjin, China. Tianjin BOAI Pharmaceutical Co. was acquired by Asia Leechdom Holding Corp. on June 24, 2008 for $1.13 million. The Chinese company was founded by Haiwei He.

Asia Leechdom Holding Corp. manufactures and distributes pharmaceutical products. They are a producer and distributor of pharmaceutical products including a variety of medical supplies, prescription and over-the-counter, or OTC, drugs in China and abroad. Through their wholly-owned PRC subsidiary, BOAI Pharm and BOAI Pharm's wholly-owned subsidiary, BOAI Leechdom, they produce and sell medicines and distribute medicines and medical devices for third-party producers and manufacturers. They market their products through a sales network covering provinces and municipalities in China, including Beijing, Shanghai, Shandong, and Guangdong. They also export their products through third-party exporters to customers in North America, Europe and East Asia. Their subsidiary, BOAI Pharm is the original design manufacturer, or ODM, for twelve products branded by both domestic and international pharmaceutical companies. Their ODM Products, including products sold under the 'American Ginseng Tea,' 'Wild Ginseng Tea,' and 'Ginseng Tea,' brands are exported to end-users in Canada, Europe and Asia through the Northern International Group Tianjin Pharmaceutical Import and Export Co., Ltd., or Northern International. They receive product orders from Northern International along with a deposit for such products. They then arrange for the production, packaging and transportation of the product to a warehouse designated by Northern International and then receive payment. They produce their products at production facility located in Tianjin, China. They operate production lines, each serving the following product formats: (1) ointment, (2) pill, (3) tablet, (4) syrup, (5) granule, (6) capsule, (7) orally taken liquid, (8) plaster and (9) extract; and further separated into liquid preparations (such as ointment and syrup) and solid preparations (such as tablets, pills and granules). They recently obtained land use rights for another 85,938.92 square meters of property for construction of an additional production facility in Tianjin.

Asia Leechdom Holding Corp. manufactures and distributes pharmaceutical products. They are a producer and distributor of pharmaceutical products including a variety of medical supplies, prescription and over-the-counter, or OTC, drugs in China and abroad. Through their wholly-owned PRC subsidiary, BOAI Pharm and BOAI Pharm's wholly-owned subsidiary, BOAI Leechdom, they produce and sell medicines and distribute medicines and medical devices for third-party producers and manufacturers. They market their products through a sales network covering provinces and municipalities in China, including Beijing, Shanghai, Shandong, and Guangdong. They also export their products through third-party exporters to customers in North America, Europe and East Asia. Their subsidiary, BOAI Pharm is the original design manufacturer, or ODM, for twelve products branded by both domestic and international pharmaceutical companies. Their ODM Products, including products sold under the 'American Ginseng Tea,' 'Wild Ginseng Tea,' and 'Ginseng Tea,' brands are exported to end-users in Canada, Europe and Asia through the Northern International Group Tianjin Pharmaceutical Import and Export Co., Ltd., or Northern International. They receive product orders from Northern International along with a deposit for such products. They then arrange for the production, packaging and transportation of the product to a warehouse designated by Northern International and then receive payment. They produce their products at production facility located in Tianjin, China. They operate production lines, each serving the following product formats: (1) ointment, (2) pill, (3) tablet, (4) syrup, (5) granule, (6) capsule, (7) orally taken liquid, (8) plaster and (9) extract; and further separated into liquid preparations (such as ointment and syrup) and solid preparations (such as tablets, pills and granules). They recently obtained land use rights for another 85,938.92 square meters of property for construction of an additional production facility in Tianjin.